Apple Inc. (AAPL) Should Expedite Share Repurchases

Page 1 of 2

Apple Inc. (NASDAQ:AAPL)’s cash hoard of more than $137 Billion is constantly in the limelight, and even more so with an activist investor raising additional concerns about the cash. After the recent sell-off of Apple Inc. (NASDAQ:AAPL) shares amidst worries on margins and innovation, the companies dividend yield in excess of 2.2% looks quite decent.

The company announced a share repurchase plan worth $10 Billion until 2015, but primarily to offset dilution arising from employee stock options. With the stock languishing near 52 week lows, and the intrinsic value of the company slated to be much higher than the current share price, now is the time to ramp up that share repurchase plan for a much bigger buyback.

Apple Inc. (NASDAQ:AAPL)Low Interest Environment

The company’s oversized cash balance is barely earning pennies on the dollar, as funds are primarily invested in government securities and investment grade corporate bonds in the U.S. and abroad. The weighted average interest rate for its cash and securities position for its most recent quarter was a paltry 1.07%.

Understandably, shareholders are questioning the company’s capital allocation strategies. With the Fed’s stance pretty clear on keeping interest rates low until at least late 2014, returns from fixed income securities will remain poor unless further action is taken.

“Fooling All of the Shareholders This Time”

David Einhorn of Greenlight Capital raised eyebrows when he sued Apple Inc. (NASDAQ:AAPL) and while he was simultaneously pushing the company to issue perpetual preferred stock with a 4% yield. Einhorn gained fame with his now famous book, “Fooling Some of the People All of the Time” and for short positions on Green Mountain, Lehman Brothers and Allied Capital. However, who is Einhorn really trying to fool this time?

Einhorn deserves credit for bringing the cash issue more into the limelight and paving the way for more thoughtful discussions. But it is pretty much a self-serving stance, and even more so, because his fund is in the red. However, the issuance of preferred stock is a pretty bad idea.

This shouldn’t be a major surprise as Einhorn’s fund lost a lot of money betting big on Apple Inc. (NASDAQ:AAPL) stock and a short position on Green Mountain Coffee Roasters Inc. (NASDAQ:GMCR). Einhorn’s bet on Green Mountain went sour after the specialty coffee-maker of the famous K-Cups rallied heavily after posting good numbers amidst worries of patent expirations, and a decent outlook for 2013.

Downsides of Preferred Stock

The preferred stock idea pitched by Einhorn might look very good on paper. But it’s actually a bad idea, preferred stock is just like vanilla debt except the obligations are not as harsh. Issuing tradable preferred stock is not going to alter or enhance the value of the company. Preferred stock has more senior claims relative to common stock, and as a result common-shareholders will actually be more subordinated in the hierarchy.

And most importantly, there is no tax benefit to be realized from preferred stock dividends. Interest from issuing straight debt is tax deductible, which provides a great incentive for corporations, which preferred dividends don’t have.

Current Buy Back Plan And Offshore Cash

Apple Inc. (NASDAQ:AAPL) has already utilized a sizable portion of the buyback plan in place. In Q1 F2013, Apple already repurchased shares worth $1.95 Billion through an accelerated share repurchase program with a bank. However, due to the current low valuation of the stock, Apple should expedite the remaining balance of the announced share buyback program using multiple banks.

An impediment to doing a buyback is that more than two-thirds of Apple Inc. (NASDAQ:AAPL)’s cash is located offshore, i.e. roughly $94 billion. The company has to pay a massive tax bill at current corporate tax rates for repatriation. Apple is not the only company with this headache, arch-rival Google Inc (NASDAQ:GOOG) also has a majority of its $48 billion located offshore, i.e. $31 billion.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!